Gaudium IVF Lists at 5% Premium Over IPO Price on NSE, Exceeds Grey Market Estimates

Gaudium IVF Lists at 5% Premium on NSE, Becomes First Fertility Care Company to Tap Public Markets

Gaudium IVF, a pioneer in assisted reproductive technologies in India, listed its shares on the National Stock Exchange (NSE) at a 5% premium over its initial public offer (IPO) price of Rs 79 per share, beating grey market estimates. The shares were listed at Rs 83 per share on the NSE and BSE.

The company's IPO, which closed on February 24, received a 7.27 times subscription in the primary market between February 20-24. The Rs 165-crore IPO had a price band of Rs 75-79 per share, with proceeds intended to establish 19 new IVF centres across India, pay off debt, and fund general corporate purposes.

Founded by Khanna, Gaudium IVF operates through a hub-and-spoke model, with seven hubs and 28 spokes across multiple states. Financially, the company reported revenue from operations of Rs 70.72 crore and a profit after tax (PAT) of Rs 19.13 crore for the financial year ending March 31, 2025. In FY24, revenue was Rs 47.89 crore, with a PAT of Rs 10.31 crore.

Read also: CMR Green Technologies IPO Update: Day 2 Subscription Figures Exceed Expectations

The company's market capitalisation post listing of shares stood at Rs 604.13 crore. Gaudium IVF's listing marks a significant milestone in the fertility care sector, making it the first company to tap the public markets.